Category: Providers

AbbVie Adds Cancer Drug to Contract Pharmacy Restriction Policy

April 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Drug manufacturer AbbVie recently added a cancer medication to its 340B contract pharmacy restrictions for hospitals.

Drug manufacturer AbbVie is adding a cancer treatment to the list of drug products that only will be available to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Four More Drugmakers to End 340B Contract Pharmacy Restrictions in Arkansas Following Appeals Court Decision

April 2, 2024 William Newton, Associate Editor/Senior Writer Views

At least nine drugmakers have modified their contract pharmacy restrictions in Arkansas after the state said it planned to enforce its 340B law following an appeals court decision. An additional nine manufacturers loosened restrictions prior to the court decision.

Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sumitomo Is Thirty-Second Company to Implement Contract Pharmacy Restrictions

April 2, 2024 Rich Daly, Editor in Chief Views

Sumitomo is the 32nd pharmaceutical manufacturer to place restrictions on 340B drug shipment in the contract pharmacy setting.

Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Astellas Adds Second Drug to 340B Contract Pharmacy Restrictions

April 2, 2024 William Newton, Associate Editor/Senior Writer Views

Pharmaceutical manufacturer Astellas recently added a second medication to its 340B contract pharmacy restrictions.

Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amgen, J&J to Issue Refunds on High-Selling Drugs to 340B Providers

April 2, 2024 Rich Daly, Editor in Chief Views

Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Estimated 340B Revenue Exceeded Charity Care Spending for 85% of DSH Hospitals, Says Pharma-backed Group

April 2, 2024 Rich Daly, Editor in Chief Views

340B revenue exceeds charity care spending for most DSH hospitals, said a report from drug industry-backed AIR340B.

Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

West Virginia Providers Praise Newly Passed State 340B Contract Pharmacy Protection Law

March 28, 2024 William Newton, Associate Editor/Senior Writer Views

West Virginia providers said they strongly support the 340B contract pharmacy protection bill that Gov. Jim Justice (R) signed into law on March 27.

West Virginia provider groups are applauding a newly passed law to bar drugmaker 340B contract pharmacy restrictions in the state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Gaps in Hospital Financial Data Limit 340B Transparency, Analysis Says

March 28, 2024 William Newton, Associate Editor/Senior Writer Views

A KFF issue brief examined gaps in available data on hospitals and health systems' finances and use of the 340B program.

Significant gaps in hospital and health system’s financial data, including 340B program use, “limit transparency for policymakers, researchers, and consumers,” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Three 340B Terminations, Seven Paybacks to Manufacturers in Latest Provider Audit Findings

March 28, 2024 Rich Daly, Editor in Chief Views

Federal regulators released a March 20 update to ongoing 340B program integrity audits for fiscal year 2023.

Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Judge Dismisses Health System’s Penny Pricing Coordination Lawsuit Against Drugmakers

March 26, 2024 Rich Daly, Editor in Chief Views

A federal district judge has dismissed Calif.-based Adventist West's lawsuit against four drug manufacturers.

A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live